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the film revealed that the mole
rats had the remarkable ability to
move the lower pair of incisors
independently of one another. But
the researchers found
subsequently that there was more
to the teeth than movement and
their anatomical studies began by
looking at the cortical responses
to touch sensations of
anaesthetized animals. 
Microelectrodes were used to
record multiunit neuronal activity
at over 1,000 different cortical
sites in four adult mole rats. Each
electrical penetration site was
marked on an enlarged photo of
the brain and the skin surface was
stimulated with small probes and
fine paint brushes to determine
the location and size of receptor
fields on the body for neurons at
each electrode penetration.
When they analyzed the brains
taken from these rats they found
that almost one third of primary
somatosensory cortex is devoted
to representations of the upper
and lower incisors.
Representations from the other
parts of the body paled in
comparison: the rest of the head
comprised 18 per cent, the trunk
and tail 13.5 per cent, the fore
paw 10 per cent and the hind paw
8 per cent.
In addition the somatosensory
cortex is greatly enlarged in naked
mole rats compared with the
laboratory rat. The researchers
found that the somatosensory
cortex had extended to parts of
the neocortex that processes
visual information in other species
with sight and represents an
analogous but vastly greater
expansion of compensating
plasticity seen in animals that
have lost their vision.
But the representation of stimuli
via the teeth caught the
researchers by surprise. “Although
dentition is important in virtually all
mammals, the degree of cortical
magnification of mole-rat incisors
is unprecedented,” the researchers
say. They wonder why so much
cortical attention has been focused
on teeth. “Can mole rats use the
dentition for a range of subtle
sensory discriminations?” They
don’t posit an answer but believe
these animals may yet have more
evolutionary lessons to teach.
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Heterodimeric αβ integrins contain
a von Willebrand Factor type A
(vWFA) domain, βA, in their β
subunits; nine integrins also
contain a second such domain,
αA, in their α subunits (reviewed in
[1]). In response to ‘inside-out’
activation, ligand binding to
integrins is mediated by αA if
present [2], and if not by βA [3]. In
both instances, a ligand-derived
acidic residue binds at the metal-
ion-dependent-adhesion-site
(MIDAS) of αA or βA [3,4].
Regardless, similar outside-in
signals are generated in response.
The shared inside-out and
outside-in signaling features in
αA-containing and αA-lacking
integrins suggest a common
pathway of activation and
signaling. Based on the structure
of the ligand-binding site in the
αA-lacking integrin αVβ3 [3] and
the known structure–activity
relationships in αA [4–9], we
suggest that αA serves as an
endogenous ligand for βA
(Figure 1), providing an
explanation for the shared
features in stimulus–response
coupling. In this scenario, βA
mediates ligand binding in all
integrins, either directly in αA-
lacking integrins, or indirectly 
in the αA-containing variants. 
In this work, we present our
rationale for this hypothesis 
and provide supporting
biochemical data.
Three observations provide the
basis for our hypothesis. First, αA
emerges from the propeller’s
D3–A3 loop, which forms part of
the ligand-binding interface in
αVβ3 [3]. Thus, the amino- and
carboxy-termini of αA are
expected to be very close to the
βA MIDAS. Second, isolated αA
mediates high-affinity interaction
with physiological ligands [8,9].
However, this interaction is
regulated by βA in the
holoreceptors, as mutations of βA
MIDAS residues in β1 or β2
integrins markedly reduce αA-
mediated ligand binding and
expression of activation-sensitive
epitopes [9–11]. Third, integrin
ligands uniformly have a flexible
and solvent-exposed acidic
residue that contacts the integrin
through a metal ion [3,5]. We note
that the carboxy-terminal α7 helix
of αA [8,12] is followed by an
invariant Glu within a conserved
tetrapeptide (Figure 1B). As αA
switches from its inactive, closed
state to its active open state
[6,8,9], a 10 Å downward shift of
α7 drastically alters the position of
the invariant Glu relative to the βA
MIDAS, and we suggest that this
shift enables the Glu side chain to
coordinate the metal ion in βA
MIDAS in a manner similar to that
of the ligand Asp in ‘liganded’
αVβ3 [3] (Figure 1C). The last three
amino acids of the α7 helix
extending into the linker sequence
that includes the invariant Glu
become disordered in the open
form of αA and presumably
flexible [6,8,13], even in the
context of the heterodimer [9]. In
addition, the amino- and carboxy-
terminal linkers flanking αA
appear to be solvent-accessible,
as they contain epitopes for
inhibitory monoclonal antibodies
(mAbs) [9,14].
Our hypothesis predicts that
mutations of the invariant Glu 
will impair binding of αA integrins
to activation-dependent ligands
without affecting their interaction
with activation-independent
ligands. The former condition has
been established for CD11a/CD18
[7]. To evaluate the latter
condition and the applicability 
of this hypothesis to other
integrins, we tested the role of 
the invariant Glu in integrin–ligand
interactions using another αA-
integrin CD11b/CD18.
Substitutions of this Glu (Glu320
in CD11b) to Ala (E320A), Gln
(E320Q) or Asp (E320D) were
introduced and expression and
function of the resulting receptors
[6] assessed in human 293
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epithelial cells, which lack
endogenous CD11b/CD18. 
The mutations did not impair
surface expression of
CD11b/CD18 or heterodimer
formation (Figure 2A). The mutant
and wild-type receptors also
reacted equally well with the
activating mAbs KIM185 and
KIM127 (Figure 2A), which
recognize regions within the CD18
‘leg’ segment [15].
We next carried out binding
studies using the activation-
dependent physiological ligand
iC3b, which binds to the αA
MIDAS face in native
CD11b/CD18 [6]. We found that
binding of E320A and E320Q
receptors to iC3b was markedly
reduced (Figure 2B). The E320D
mutation was better tolerated
(Figure 2B), suggesting that the
charge of the amino acid
sidechain is a key determinant of
binding. Further activation of the
E320A integrin by KIM185 or
KIM127 mAbs [16] increased its
binding to iC3b, but with
consistently lower levels than that
of the wild-type integrin
(Figure 2B). Significantly, none of
the three mutations affected
binding to neutrophil inhibitory
factor (NIF) and the ligand-
mimetic mAb 107 (Figure 2B, and
data not shown), both of which
are activation-independent
ligands that bind to CD11b 
MIDAS [17]. The E320A receptor
failed to express the activation
and cation-sensitive epitope for
mAb 24 [18] (Figure 2B), which
binds to βA when αA is locked in
the open conformation [9]. Loss of
mAb 24 binding is also seen in
alanine substitutions of the βA
MIDAS residues in the same
integrin [10]. The mAb 24 binding
data suggest that the proposed
‘glutamate bridge’ linking αA to βA
may also facilitate outside-in
signaling. The fact that the E320A
mutation does not completely
abolish iC3b binding is not
surprising but indicative of
additional contacts of αA with βA,
perhaps involving the conserved
tetrapeptide and adjacent linker
residues [7].
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Figure 1. Model of active αA as an endogenous ligand for βA.
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(light blue) projects from the D3–A3 loop in the propeller. The
metal ions at αA and βA MIDAS are in light red and cyan
respectively. The carboxy-terminal linker connecting αA to the
propeller is outlined in yellow. The amino-terminal linker is not
shown. The dotted box represents the αA ligand Glu (E).
(B) Conservation of the invariant Glu in αA-integrins. The
sequences of the human α-subunits were aligned with
CLUSTALW 1.8; the invariant Glu (red) within a conserved
tetrapeptide (gray shading) is shown. The α7 helix in closed αA
is underlined. Secondary structure assignments (underlined)
are based on the crystal structures of αVβ3 and αA from
CD11b [13,19]. Amino acids are represented with single letters.
(C) Hypothetical model of the αA-integrin CD11b/CD18, depict-
ing Glu320 in the closed (left) and open (active) (right) states of
αA. The metal ions at the βA MIDAS, ADMIDAS and LIMBS [3]
are in cyan, violet and gray respectively. The αA MIDAS metal
is in light red. The left panel features βA in the ‘unliganded’
state [19], and the right panel shows βA in the ‘liganded’ state
[3]. No structural information is currently available on the
linkers connecting the amino- and carboxy-termini of αA to the
propeller, and thus the precise quaternary arrangements of αA
will have to await experimental structural information. The
model was built in Modeller 4.0 [20] using the αVβ3 structures
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hypothesis. The carboxy-terminal linker contains a second
conserved Glu (Glu333 in CD11b); however in our model this
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interact with it.
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Figure 2. Expression and function of CD11b/CD18 mutants.
(A) Histograms showing the relative binding of the anti-CD11b
mAb 44a, and the anti-CD18 mAbs (TS1/18, KIM185 and
KIM127) to 293 cells expressing wild-type (WT) and mutant
CD11b/CD18. Binding was normalized to that of the anti-
CD11b mAb 903 (which binds outside αA) as previously
described [6]. (Inset) Western blots from two experiments
showing the presence of CD18 in anti-CD11b (using mAb 44a)
immunoprecipitates from 293 cells expressing wild-type or
mutant CD11b/CD18. Arrowheads indicate molecular weight
markers at 205 kDa, 97.4 kDa and 68 kDa. Each sample was
run in duplicate and probed with 44a or anti-CD18 mAbs [6]. In
the inset, the upper part of one gel probed with mAb 44a
(above dotted line) and the lower part of the duplicate gel
probed with polyclonal anti-CD18 are shown. No CD18 was
seen in anti-CD11b immunoprecipitates from mock-transfected
293 cells (Mock). (B) Histograms showing the relative binding
of iC3b to WT and mutant CD11b/CD18 in Ca2+, Mg2+ (1 mM
each) containing buffer, Mn2+ (0.5mM) containing buffer, or
Ca2+, Mg2+ buffer containing the activating mAbs KIM127 or
KIM185. Also shown are histograms with relative binding of NIF
and mAb107 to WT and E320A in the Ca2+, Mg2+ buffer. All his-
tograms show the mean ± SD of quadruplet determinations
from a representative experiment (one of three performed). The
methods used were as described [6], except that 293 cells
were transfected and attached to poly-L-lysine coated plastic
wells before performing the various binding assays. Binding of
mAbs 24 [10], mAb 107 [17] and KIM127 and 185 [15] were
done as described.
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